Related to International Institute of Biomedical Sciences and Technology Has Been Formed by Institutes in NY, Israel, and Taiwan

• S-Evans Biosciences Gains Chinese Rights to Cryo-Cell’s Menstrual Stem Cell Technology
  
• Ono Gains Rights to Tioga’s IBS Therapy in Japan, South Korea, and Taiwan
  
• PerkinElmer Makes Two Acquisitions to Pad Diagnostics Business in Emerging Markets
  
• BMS Sells Asia Pacific OTC Assets to Taisho for $310M
  
• Corning Puts Down $400M for Axygen to Expand Consumables Portfolio and Presence in Asia
  
• Wellcome Trust and Merck Set Up JV to Focus on Vaccines for Developing Nations
  
• Prodrug of Eisai’s Antifungal to Be Investigated in Chagas
  
• YM BioSciences to Take Over Cytopia Gaining Base in Australia
  
• GSK Furthers Interest in China through Pediatric Vaccines JV with Initial $32M Investment
  
• Merck KGaA and Lonza Separately Acquire Indian Bioscience Companies
  
• Genetic Tech to Distribute Rosetta’s Cancer Tests in Australia, New Zealand, and Singapore
  
• PPD to Spin Out Compound-Partnering Segment, Acquire Chinese CRO, and Invest $100M in Celtic Therapeutics
  
• Simcere Fortifies Stake in Chinese H1N1 Vaccine Firm to Over 50%
  
• Novartis to Invest $1.25B in Two New Facilities in China
  
• Novartis to Buy 85% of Chinese Vaccines Company for $125M
  
• Wanbang to Advance D-Pharm’s Late-Stage Stroke Therapy in China
  
• Astellas Enters Asian Licensing Agreement for Ironwood’s Phase III IBS Therapy with $30M
  
• PPD Acquires BioDuro to Further Expand Its Outsourcing Capabilities in China
  
• Nacalai Gains Distribution Rights to  LifeSensors’ Products in Asian Market
  
• CLC bio to Provide Next-Generation Sequencing Solutions in Japan Through Filgen